Another transgenic mouse model, LA1-K-Ras2, where the K-Ras2G12D allele can be activated by a somatic intrachromosomal recombination event, showed high incidence of lung tumours but, also a 30% incidence of thymic lymphoma and other tumour types [31]. The gene discussed is KRAS; the disease is neoplasm.